These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 39086433)

  • 1. Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy.
    Hachmann M; Gülcan G; Rajendran R; Höring M; Liebisch G; Bachhuka A; Kohlhaas M; Maack C; Ergün S; Dudek J; Karnati S
    Front Mol Med; 2024; 4():1389456. PubMed ID: 39086433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
    Le CH; Benage LG; Specht KS; Li Puma LC; Mulligan CM; Heuberger AL; Prenni JE; Claypool SM; Chatfield KC; Sparagna GC; Chicco AJ
    J Biol Chem; 2020 Aug; 295(35):12485-12497. PubMed ID: 32665401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
    Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of mitophagy ameliorates cardiomyopathy in Barth syndrome.
    Zhang J; Liu X; Nie J; Shi Y
    Autophagy; 2022 Sep; 18(9):2134-2149. PubMed ID: 34985382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid abnormalities in children with Barth syndrome.
    Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ
    J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy.
    Cole LK; Mejia EM; Sparagna GC; Vandel M; Xiang B; Han X; Dedousis N; Kaufman BA; Dolinsky VW; Hatch GM
    J Mol Cell Cardiol; 2020 Jul; 144():24-34. PubMed ID: 32418915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy.
    Zhu S; Chen Z; Zhu M; Shen Y; Leon LJ; Chi L; Spinozzi S; Tan C; Gu Y; Nguyen A; Zhou Y; Feng W; Vaz FM; Wang X; Gustafsson AB; Evans SM; Kunfu O; Fang X
    Circ Heart Fail; 2021 Jun; 14(6):e008289. PubMed ID: 34129362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.
    Kimura T; Kimura AK; Ren M; Berno B; Xu Y; Schlame M; Epand RM
    Biochemistry; 2018 Apr; 57(14):2162-2175. PubMed ID: 29557170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Mitochondrial Ca
    Bertero E; Nickel A; Kohlhaas M; Hohl M; Sequeira V; Brune C; Schwemmlein J; Abeßer M; Schuh K; Kutschka I; Carlein C; Münker K; Atighetchi S; Müller A; Kazakov A; Kappl R; von der Malsburg K; van der Laan M; Schiuma AF; Böhm M; Laufs U; Hoth M; Rehling P; Kuhn M; Dudek J; von der Malsburg A; Prates Roma L; Maack C
    Circulation; 2021 Nov; 144(21):1694-1713. PubMed ID: 34648376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmalogen loss caused by remodeling deficiency in mitochondria.
    Kimura T; Kimura AK; Ren M; Monteiro V; Xu Y; Berno B; Schlame M; Epand RM
    Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31434794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Barth Syndrome Patient-Derived
    Snider PL; Sierra Potchanant EA; Sun Z; Edwards DM; Chan KK; Matias C; Awata J; Sheth A; Pride PM; Payne RM; Rubart M; Brault JJ; Chin MT; Nalepa G; Conway SJ
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation.
    Greenwell AA; Gopal K; Altamimi TR; Saed CT; Wang F; Tabatabaei Dakhili SA; Ho KL; Zhang L; Eaton F; Kruger J; Al Batran R; Lopaschuk GD; Oudit GY; Ussher JR
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2255-H2269. PubMed ID: 33929899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV9-
    Suzuki-Hatano S; Saha M; Soustek MS; Kang PB; Byrne BJ; Cade WT; Pacak CA
    Mol Ther Methods Clin Dev; 2019 Jun; 13():167-179. PubMed ID: 30788385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.
    Russo S; De Rasmo D; Signorile A; Corcelli A; Lobasso S
    Sci Rep; 2022 Nov; 12(1):19847. PubMed ID: 36400945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell Studies.
    Saric A; Andreau K; Armand AS; Møller IM; Petit PX
    Front Genet; 2015; 6():359. PubMed ID: 26834781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide.
    Sabbah HN
    Heart Fail Rev; 2021 Mar; 26(2):237-253. PubMed ID: 33001359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.
    Soustek MS; Falk DJ; Mah CS; Toth MJ; Schlame M; Lewin AS; Byrne BJ
    Hum Gene Ther; 2011 Jul; 22(7):865-71. PubMed ID: 21091282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipid environment modulates cardiolipin and phospholipid constitution in wild type and tafazzin-deficient cells.
    Oemer G; Koch J; Wohlfarter Y; Lackner K; Gebert REM; Geley S; Zschocke J; Keller MA
    J Inherit Metab Dis; 2022 Jan; 45(1):38-50. PubMed ID: 34494285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
    Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
    J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
    Hsu P; Liu X; Zhang J; Wang HG; Ye JM; Shi Y
    Autophagy; 2015 Apr; 11(4):643-52. PubMed ID: 25919711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.